ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
23 announcements
Insecticides (India) Ltd will hold a board meeting on November 5, 2026, to approve its Q2 financial results. The trading window remains closed from October 1 until the results declaration.
Insecticides (India) Ltd conducted its 29th Annual General Meeting on August 12, 2026. Shareholders deliberated on seven agenda items, with voting results to be disclosed later.
Q1FY27 was impacted by delayed monsoons, shifting demand later. Despite revenue decline, gross margins improved due to premiumization and inventory management, though EBITDA softened on negative operating leverage.
Insecticides (India) Limited reported Q1 FY27 revenue of ₹612 crore, a 12% YoY decline. Profit after tax stood at ₹44 crore amid rainfall deficits across India.
IIL reported FY26 turnover of ₹2,140 Cr, focusing on premiumization via its 'Tractor Brand'. Strategy emphasizes innovative product launches and international collaborations to shift towards high-margin B2C segments.
Insecticides (India) Ltd reported revenue from operations of ₹611.5 Cr (-11.5% YoY) and net profit of ₹43.9 Cr (-24.4% YoY) for Q1 FY27.
Insecticides (India) Ltd scheduled a board meeting for August 11, 2026. The meeting will consider unaudited financial results for the quarter ended June 30, 2026.
Insecticides (India) Limited submitted its Business Responsibility and Sustainability Report for FY 2025-26. The report is an integral part of the company's Annual Report.
Insecticides (India) Limited convened its 29th AGM for August 12, 2026. Key agenda items include approving a new ESPS scheme and confirming a Rs. 2 dividend.
Insecticides (India) Limited released its Annual Report for FY 2025-26. The 29th AGM is scheduled for August 12, 2026, via video conferencing.
IIL delivered FY26 revenue of ₹2,140cr (up 7%) with EBITDA of ₹227cr. Strategy focuses on premiumization via the Kaeros brand and R&D partnerships with Nissan and Corteva.
Insecticides India delivered steady 7% revenue growth in FY26, balancing raw material inflation through premiumization and strategic partnerships while preparing for a major brand expansion via its new subsidiary, Kairos.
Insecticides (India) Limited appointed Sanskar Aggarwal as Executive Director and Atul Kumar as VP-Sales. Concurrently, Mrs. Nikunj Aggarwal resigned from her Executive Director position.
Insecticides (India) Limited submitted its Annual Secretarial Compliance Report for the financial year 2026. The report confirms overall regulatory adherence and governance standards for the period.
Insecticides (India) Ltd reported FY26 revenue of ₹2,140 Crore, a 7% annual increase. Q4 revenue surged 19% driven by premium product growth and new launches.
Insecticides (India) reported FY26 turnover of ₹2,140 Cr. Company shifting toward premiumization with B2C premium product share rising from 51% (FY23) to 58% (FY26).
Insecticides (India) Ltd reported revenue from operations of ₹426.3 Cr (+18.8% YoY) and net profit of ₹11.7 Cr (-15.8% YoY) for Q4 FY26.
Insecticides (India) reported a standalone FY26 net profit of ₹135.82 Crore. The board also approved a new employee stock purchase scheme and leadership changes.
Insecticides (India) Limited launched GRANUVIA™, a next-generation insecticide for controlling stem borer and BPH in paddy. This product strengthens their crop protection portfolio in India.
Mr. Sanjay Vats resigned as VP-Sales & Marketing and subsidiary Director effective May 13, 2026. The departure is due to personal reasons with immediate effect.
Insecticides (India) Limited announced that CRISIL has reaffirmed its credit ratings. The Long-Term Rating remains 'CRISIL A+/Stable' and the Short-Term Rating remains 'CRISIL A1'. The ratings cover bank loan facilities and remain unchanged compared to the previous financial year.
Insecticides (India) Ltd reported net profit of ₹10.5 Cr (-39.7% YoY) for Q3 FY26.
Insecticides (India) Ltd submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended March 31, 2026. The registrar, Alankit Assignments Limited, confirmed that no physical share certificates were received for dematerialisation during this period. This is a routine administrative filing with no material impact on business operations.